Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 276-283

  Willson, Timothy M ^a   Lehmann, Jürgen M ^a   Kliewer, Steven A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CELL NUCLEUS RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR; PROSTAGLANDIN D2; THIAZOLIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG POTENCY; OBESITY; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0030451897     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18622.x     Document Type: Conference Paper

References (25)

1. HULIN, B. 1994. New hypoglycemic agents. Prog. Med. Chem. 31: 1-58.
2. KAWAMATSU, Y., T. SARAIE, E. IMAMIYA, K. NISHIKAWA & Y. HAMURO. 1980. Studies on antihyperlipidemic agents. Arzneim.-Forsch./Drug Res. 30: 454-459.
3. SOHDA, T., K. MIZUNO, E. IMAMIYA, Y. SUGIYAMA, T. FUJITA & Y. KAWAMATSU. 1982. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives. Chem. Pharm. Bull. 30: 3580-3600.
4. SHODA, T., Y. MOMOSE, K. MEGURO, Y. KAWAMATSU, Y. SUGIYAMA & H. IKEDA. 1990. Studies on antidiabetic agents: Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones. Arzneim.-Forsch./Drug Res. 40: 37-42.
5. CANTELLO, B. C. C., M. A. CAWTHORNE, G. P. COTTAM, P. T. DUFF, D. HAIGH, R. M. HINDLEY, C. A. LISTER, S. A. SMITH & P. L. THURLBY. 1994. [[ω-(heterocycrylamino)alkoxy-]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 37: 3977-3985.
6. CHAWLA, A., E. J. SCHWARTZ, D. D. DIMACULANGAN & M. A. LAZAR. 1994. Peroxisome Proliferator-Activated Receptor (PPAR) γ: Adipose-predominant expression and induction early in adipose differentiation. Endocrinology 135: 798-800.
7. TONTONOZ, P., E. HU & B. M. SPIEGELMAN. 1994. Stimulation of adipogenesis in fibroblasts by PPAR-γ, a lipid-activated transcription factor. Cell 79: 1147-1156.
8. HIRAGUN, A., M. SATO & H. MITSUI. 1988. Preadipocyte differentiation in vitro: Identification of a highly active adipogenic agent. J. Cell. Physiol. 134: 124-130.
9. KLETZIEN, R. F., S. D. CLARKE & R. G. ULRICH. 1992. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Pharmacol. 41: 393-398.
10. HARRIS, P. K. W. & R. F. KLETZEIN. 1994. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol. Pharmacol. 45: 439-445.
11. TONTONOZ, P., R. A. GRAVES, A. I. BUDAVARI, H. ERDJUMENT-BROMAGE, M. LUI, E. HU, P. TEMPST & B. M. SPIEGELMAN. 1994. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα. Nucleic Acids Res. 22: 5628-5634.
12. IBRAHIMI, A., L. TEBOUL, D. GAILLARD, E. AMRI, G. AILHAUD, P. YOUNG, M. A. CAWTHORNE & P. A. GRIMALDI. 1994. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol. Pharmacol. 46: 1070-1076.
13. LEHMANN, J. M., L. B. MOORE, T. A. SMITH-OLIVER, W. O. WILKISON, T. M. WILLSON & S. A. KLIEWER. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270: 12953-12956.
14. OAKES, N. D., C. J. KENNEDY, A. B. JENKINS, D. R. LAYBUTT, D. J. CHISHOLM & E. W. KRAEGEN. 1994. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43: 1203-1210.
15. MCGARRY, J. D. 1994. Disordered metabolism in diabetes: Have we underemphasized the fat component? J. Cell. Biochem. 55S: 29-38.
16. FLIER, J. S. 1995. The adipocyte: Storage depot or node on the energy information super-highway. Cell 80: 15-18.
17. GÖTTLICHER, M. E., E. WIDMARK, Q. LI & J. A. GUSTAFSSON. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89: 4653-4657.
18. KELLER, H., A. MAHFOUDI, C. DREYER, A. K. HIHI, J. MEDIN, K. OZATO & W. WAHLI. 1993. Peroxisome proliferator-activated receptors and lipid metabolism. Ann. N.Y. Acad. Sci. 684: 157-173.
19. DESVERGNE, B. & W. WAHLI. 1995. PPAR: a key nuclear factor in nutrient/gene interaction? In Inducible Gene Expression, vol. 1. P. A. Baeuerle, Ed.: 142-176. Birkhäuser. Boston, MA.
20. 2. Prostaglandins 35: 277-300.
21. 2 in nuclei. J. Pharmacol. Exper. Ther. 242: 306-311.
22. 2 and related compounds: An update. Prostaglandins, Leukotrienes Essent. Fatty Acids 47: 1-12.
23. WAHLI, W. Personal Communication.
24. 2 production is likely antigen-presenting cells. J. Immunol. 143: 2982-2989.
25. 2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260: 521-531.